Direct medical costs of opioid management and the functional status of subjects with poly-trauma history >two ears and chronic non-cancer pain: impact on health care utilization and life care planning

2011 ◽  
Vol 12 (4) ◽  
pp. P60
Author(s):  
A. Miciano
Keyword(s):  
Health Care ◽  
Health Care Utilization ◽  
Cancer Pain ◽  
Functional Status ◽  
Medical Costs ◽  
Care Utilization ◽  
Care Planning ◽  
Life Care ◽  
Trauma History ◽  
Direct Medical Costs

scholarly journals Health Care Utilization and Direct Medical Costs of Tennis Elbow

2016 ◽  
Vol 8 (4) ◽  
pp. 355-358 ◽  
Author(s):  
Thomas L. Sanders ◽  
Hilal Maradit Kremers ◽  
Andrew J. Bryan ◽  
Jeanine E. Ransom ◽  
Bernard F. Morrey
Keyword(s):  
Health Care ◽  
Health Care Utilization ◽  
Tennis Elbow ◽  
Medical Costs ◽  
Care Utilization ◽  
Direct Medical Costs

scholarly journals HEALTH CARE UTILIZATION OUTCOMES FOR PATIENTS ENROLLED IN A LATE-LIFE CARE INTERVENTION

2017 ◽  
Vol 1 (suppl_1) ◽  
pp. 931-931
Author(s):  
K. Fernstrom ◽  
H. Britt ◽  
N. Shippee ◽  
P. Mobley
Keyword(s):  
Health Care ◽  
Health Care Utilization ◽  
Late Life ◽  
Care Utilization ◽  
Life Care ◽  
Care Intervention

Trends in Health-Care Utilization at the End of Life Among Patients With Hematologic Malignancies in a Middle-Income Country: Challenges and Opportunities in Brazil

2019 ◽  
Vol 36 (9) ◽  
pp. 775-779 ◽  
Author(s):  
Luiz Guilherme L. Soares ◽  
Renato Vieira Gomes ◽  
André M. Japiassu
Keyword(s):  
Health Care ◽  
Health Care Utilization ◽  
End Of Life ◽  
End Of Life Care ◽  
Hematologic Malignancies ◽  
Emergency Department Visits ◽  
Care Utilization ◽  
Blood Transfusions ◽  
Life Care ◽  
To Receive

Patients with hematologic malignancies (HMs) often receive poor-quality end-of-life care. This study aimed to identify trends in end-of-life care among patients with HM in Brazil. We conducted a retrospective cohort study (2015-2018) of patients who died with HM, using electronic medical records linked to health insurance databank, to evaluate outcomes consistent with health-care resource utilization at the end of life. Among 111 patients with HM, in the last 30 days of life, we found high rates of emergency department visits (67%, n = 75), intensive care unit admissions (56%, n = 62), acute renal replacement therapy (10%, n = 11), blood transfusions (45%, n = 50), and medical imaging utilization (59%, n = 66). Patients received an average of 13 days of inpatient care and the majority of them died in the hospital (53%, n = 58). We also found that almost 40% of patients (38%, n = 42) used chemotherapy in the last 14 days of life. These patients were more likely to be male (64% vs 22%; P < .001), to receive blood transfusions (57% vs 38%; P = .05), and to die in the hospital (76% vs 39%; P = .009) than patients who did not use chemotherapy in the last 14 days of life. This study suggests that patients with HM have high rates of health-care utilization at the end of life in Brazil. Patients who used chemotherapy in the last 14 days of life were more likely to receive blood transfusions and to die in the hospital.

scholarly journals Health care utilization and end-of-life care for older patients with acute myeloid leukemia

Cancer ◽  
2015 ◽  
Vol 121 (16) ◽  
pp. 2840-2848 ◽  
Author(s):  
Areej R. El-Jawahri ◽  
Gregory A. Abel ◽  
David P. Steensma ◽  
Thomas W. LeBlanc ◽  
Amir T. Fathi ◽  
...  
Keyword(s):  
Health Care ◽  
Acute Myeloid Leukemia ◽  
Health Care Utilization ◽  
End Of Life ◽  
End Of Life Care ◽  
Older Patients ◽  
Myeloid Leukemia ◽  
Care Utilization ◽  
Life Care ◽  
Acute Myeloid
Sign in / Sign up

Export Citation Format

Share Document